Breathe Well Live Well
|
Asthma Therapeutics In Asia-Pacific Market Research To Reach Over $5.6 billion 2021 – High Prevalence And Launch …
Medgadget.com (blog) MrrBiz45 The report analyzes and presents an overview on “Asthma Therapeutics In Asia-Pacific Markets To 2021 – High Prevalence And Launch Of Late-Stage Biologics Will Drive The Market In Spite Of Affordability Concerns” worldwide. Asthma is a … |
View full post on asthma – Google News
WSHU |
NY Gets More Than $1 Billion For Student Asthma Management
WSHU U.S. Senator Kirsten Gillibrand of New York has announced more than $1.6 billion in funding for school districts to help students manage their asthma. The funding is part of Gillibrand's School Asthma Management Plan Act and was included in the … Gillibrand, Lowey discuss asthma program in Port Chester School asthma management plan act is law Gillibrand and Lowey Visit Port Chester School to Talk Asthma Relief |
View full post on asthma – Google News
|
Global market for asthma treatment expected to reach $21.7 billion by 2020
News-Medical.net Despite generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global market for asthma treatment is set to … |
View full post on asthma – Google News
Nasdaq |
US Asthma Costs Reach $18 Billion
Nasdaq FRISCO, Texas, April 1, 2015 (GLOBE NEWSWIRE) — According to the Asthma and Allergy Foundation of America, 25 million Americans suffer from asthma (8% of adults, 9% of children). The disease accounts for one-quarter of all U.S. emergency room visits. |
View full post on asthma – Google News
|
U.S. Asthma Costs Reach $18 Billion
GlobeNewswire (press release) FRISCO, Texas, April 1, 2015 (GLOBE NEWSWIRE) — According to the Asthma and Allergy Foundation of America, 25 million Americans suffer from asthma (8% of adults, 9% of children). The disease accounts for one-quarter of all U.S. emergency room visits. |
View full post on asthma – Google News
|
Asthma Treatment Market (Drug) Worth $23 Billion by 2023
PR Newswire (press release) ReportsnReports.com adds PharmaPoint: Asthma – Global Drug Forecast and Market Analysis to 2023 research report that says asthma treatment market value will grow across eight major countries (the US, UK, France, Germany, Spain, Italy, Japan, and … |
View full post on asthma – Google News
|
COPD and Asthma Devices Market is Expected to Reach $34.3 Billion, Global …
PR Newswire (press release) According to a new report by Allied Market Research titled, "Global COPD and Asthma Devices Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020", the global COPD and asthma devices market would reach $34.3 billion … |
View full post on asthma – Google News
|
Asthma market to reach $23.1 billion due to targeted biologics
Drug Store News LONDON — The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries (the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia) to $23.1 billion by 2023, according to … |
View full post on asthma – Google News
The Pharma Letter |
Global asthma market to hit $18 billion by 2021 boosted by biologics
The Pharma Letter Natasha Spiller, an analyst at Datamonitor Healthcare said: “Severe asthma remains a significant cause of mortality and morbidity and a portion of patients remain inadequately treated, despite the use of inhaled corticosteroids and long-acting beta 2 … |
View full post on asthma – Google News
|
Asthma costs New York state $1.3 billion each year, study shows
Brooklyn Daily Eagle ALBANY— Asthma is costing New York's Medicaid system more than half a billion dollars a year, according to a report released Friday that urges the state to do more to help those affected by the respiratory illness. The study by state Comptroller … |
View full post on asthma – Google News